AU3332089A
(en )
1989-11-02
Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
NZ225970A
(en )
1991-01-29
Recombinant virus (avipox virus) capable of expressing a gene product without productive viral replication
NZ219515A
(en )
1989-09-27
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
AU4750390A
(en )
1990-06-12
Virus inactivated blood product and method
AU4198889A
(en )
1990-03-23
Production of bluetongue virus non-structural proteins using a baculovirus expression vector
AU1255383A
(en )
1983-09-29
Foot and mouth disease viral antigenic peptides
GB2218421B
(en )
1992-12-02
A process for producing envelope protein of japanese encephalitis virus using recombinant baculovirus; envelope proteins,recombinant baculovirus and vaccines
AU1380788A
(en )
1988-09-29
Synthetic peptide antigens for the detection of hiv-1 infection
AU8113591A
(en )
1992-01-23
Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
HUT58764A
(en )
1992-03-30
Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
AU3756789A
(en )
1990-01-12
Antagonists of viral transactivating proteins
EP0491844A4
(en )
1993-02-17
Peptides including ctl epitopes of hiv proteins and use thereof
EP0338429A3
(en )
1989-12-20
Process for the preparation of d-alpha-tocopherol from natural starting products
AU3775789A
(en )
1990-01-05
A method of evaluating recombinant vaccines against immunodeficiency virus
LTIP1795A
(en )
1995-08-25
Process for preparing protein derived from the envelope gene of human immunodeficiency virus type i and a vaccine containing said protein
EP0275196A3
(en )
1990-07-25
Protein copolymer malaria vaccine
AU2687188A
(en )
1989-06-15
New derivatives of cyclic amino acids, a process for the preparation thereof, agents containing them, and the use thereof
ZA88197B
(en )
1989-03-29
Protein copolymer malaria vaccine
AU6358190A
(en )
1991-04-08
Polypeptide vaccines against foot-and-mouth disease virus
AU3821189A
(en )
1990-01-25
Salmonella transformant capable of expression of heterologous genes and useful as a recombinant vaccine
CS138688A3
(en )
1992-06-17
Peptides possessing properties of antigenic determinant of a proteinaceous product of hiv-1 virus gene
AU6877991A
(en )
1991-06-26
A method of inactivating human immunodeficiency virus
AU8976691A
(en )
1992-06-18
Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
AU5117590A
(en )
1990-09-13
SDK peptides, a preparation process of the same and therapeutic compositions containing them
CS689787A3
(en )
1992-03-18
Peptides possessing the properties of antigenic determinants of a proteinaceous product of hiv-1 and hiv-2 env viruses gene